David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center — New York, New York

Public research footprint of David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-cell Lymphoma (DLBCL) · Advanced Solid Tumors · Advanced Solid Tumor · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05765812 — A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With… (Recruiting)
NCT06607185 — A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors (Active Not Recruiting)
NCT07114601 — A Study of LY4257496 in Participants With Cancer (OMNIRAY) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.